WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
China's air passenger trips to reach 9 million during May Day holidayChina's Zhang makes history to reach 2nd round at Monte Carlo MastersCamping becomes burgeoning trend in ChinaIn pics: Snow Town scenic spot in Hailin City, HeilongjiangSummer travel booms in countryInside the world of China's insect explorersExplainer: Why are tourist trains gaining steam in China?Xi Sends Congratulatory Letter to Zhongguancun ForumXi Story: Xi's Commitment to Empowering Chinese ChildrenChinese paddlers continue winning streak at WTT Champions Incheon